Select Page
Event info
Date:06 Feb
Time:08:30-11:00
Venue:Medicon Valley Alliance, Copenhagen

SIGN UP

Contact person
Mia Ritterband-Rosenbaum

Mia Ritterband-Rosenbaum

Event Manager & PA to CEO

mrr@mva.org

+45 21 63 38 88

How IP can help maximise the impact of digital health innovation

Medicon Valley Alliance and Potter Clarkson would like to welcome you to a Good Morning Meeting 6th of February 2025.

Innovation in digital therapeutics is booming as the possibilities offered by AI, an increased appetite to work across technologies and the growing power of data look set to help this market’s value rocket from $6.5bn in 2022 to, according to projections, more than $8.6bn in 2032.
This growth will come from more new digital therapeutic solutions to help us battle diabetes, obesity, cardiovascular, mental and behavioural health, hypertension, and insomnia and greater diversity in the scope of innovation with more software-based solutions, more wearables, more clinical decision support systems, more healthcare data mining software solutions, and more robotic surgery opportunities.
Intellectual Property (IP) will play a vital role in ensuring digital therapeutics have the greatest possible impact on global health. However, protecting digital health innovations isn’t straightforward.
Firstly, you must protect every aspect of an invention – the therapeutic, the software, the underlying algorithms, the data extrapolated and analysed and the clinical validation. Then you need to successfully tackle regulatory compliance, partnerships and collaborations and the construction of robust commercialisation and revenue models.

In this session we will explore all these issues and more, using a specially created case study to bring our practical tips into context as we show you how to identify, protect, exploit and enforce the IP that will ensure you maximise the impact of your digital health innovations.

Date: Wednesday 6th of February 2025
Time: 8:30 – 11:00
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Hub 2

 

SIGN UP

Program

8:30 Networking, registration and light breakfast
9:00 Welcome and introduction to Medicon Valley Alliance
David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance
9:05 Where is the digital health industry as we start 2025?
Benjamin Hoffmann, Partner, Patent Attorney
9:45 Key IP considerations: A fictional case study covering the IP and legal aspects that will dictate the success of a digital health invention
Jesper Sellin, Partner, IP Lawyer
Benjamin Hoffmann, Partner, Patent Attorney
Dave Clark, Partner, Patent Attorney
10:25 Conclusions: A quick recap of the key learning points
10:40 Questions
11:00 End of Good Morning Meeting

 

Speakers​​

Benjamin Hoffmann, Partner, Patent Attorney, Potter Clarkson

Heading up the growing Copenhagen office, Benjamin is a hugely experienced patent attorney and has worked across the full range of chemistry-based inventions.
Within the pharma sector, Benjamin has represented a number of large Pharma clients in oppositions/appeals at the EPO. He is also a key member of Potter Clarkson’s ‘small molecule’ pharma team, who work with clients of all sizes to provide holistic and strategic advice to companies of all sizes, from invention capture all the way through to commercialisation and IP enforcement.
Benjamin’s experience with large Pharma clients and his extensive knowledge of the life sciences market means he is now regularly instructed to conduct detailed IP due diligence into potential acquisition and investment targets.

David Clark, Partner, Patent Attorney, Potter Clarkson

Dave is an experienced UK and European patent attorney with a background in the physical sciences. He has extensive experience in drafting patent specifications, steering his clients around patent examiners, managing patent portfolios, and representing his clients’ best interests in front of the European Patent Office (EPO).
Dave now specialises in helping clients to unlock the full commercial value of computer-implemented, AI-driven and electronics-based inventions and is increasingly called upon to prove the patentability of computer implemented inventions. This is why Dave will be talking about maximising the impact of the digital side of digital health innovation in this session.

Jesper Sellin, Partner, IP Lawyer, Potter Clarkson

Based in Potter Clarkson’s Stockholm office, Jesper advises and represents Swedish and international clients on all legal matters relating to intellectual property including IP contracts, licensing models, trade marks, design, copyright, trade secrets and enforcement strategies.
He has significant experience in the medical device, digital health and Life Sciences sectors where his clients benefit from his commercial advice, negotiation skills and data protection and data management expertise as they build the most successful future for inventions. This is why Jesper will be talking about the specific legal and data considerations involved in maximising the impact of digital health innovation.

 

Organized by In collaboration with